65,437 trials
Polycystic Ovarian Syndrome
Primary: Estradiol (E2) Levels on r-hCG Day — 1668.86; 1672.80 picogram/milliliter (pg/mL)
Hypotension
Primary: Incidence of Maternal Hypotension — 10.8; 27 percentage of participants
Reduction of Post-prandial Glycaemic Response
Primary: Postprandial Glycaemic Response Index — 73.28; 83.45 percentage of AUC fagomine/AUC control — p=<0.0001
Coronary Artery Disease
Primary: Total Volume of Blood Loss From Mediastinal Chest Tubes at Time of Removal (Assuming the Total Volume of Loss is Blood). — 632; 789 mL — p=0.0493
Peri-implantitis · Periodontal Disease
Primary: Change in Total Bacterial Load on the Exposed Implant Surface — 2.77; 4.21 log (colony forming units/ml)
Human Immunodeficiency Virus Infections
Primary: Number of Subjects Needing to Switch Comparator Drugs (FPV/r or EFV) — 1; 2 participants
Vitrectomy
Primary: Percentage of Participants With Vitreous Cell Count of 0 — 88.0 Percentage of participants
Social Phobia
Primary: Social Phobia Remission
Cataract
Primary: Mean Percent Reduction in Cylinder — 32; 75; 76. percentage of reduction in cylinder — p=<0.0001
Diabetes · Admitting Hospital · Non-critically Ill
Primary: Mean Glucose — 158; 171 mg/dl
Lymphoma
Primary: Geometric Mean Area Under Curve (AUC) of Analyte, Cyclophosphamide (CP), in Aprepitant Treatment and Control Group — 300; 250 ug/mL*hr
Alzheimer's Disease
Primary: Total Score of Alzheimer's Disease Assessment Scale - Cognition Subscale (ADAS-COG)From Best Total Score (0) to Worst Total Score (70) — -1.3; -2.9; -1.5 units on a scale
Metastatic Breast Cancer
Primary: Percentage of Participants Showing an Overall Response As Assessed by the Independent Radiology Reader and by the Investigator — 37; 45; 49; 35 percentage of…
Pharmacodynamic
Primary: Change in Gastric pH After Administration of Betaine Hydrochloride (HCl) — 4.54 units on a scale
End Stage Renal Disease
Primary: Cumulative Patency at 6 Months — 83.6 percentage of participants